Diagnostics Solutions Strategic Priorities
Roche infectious diseases pipeline
Holistic portfolio coverage is a key medical value
Viral Hepatitis + STDs
Pregnancy +
Transplant
Respiratory
Vector Borne
Roche
Donor Screening
Anti-HCV
HBsAg
Anti-HBc
HIV combi PT
HIV Duo
Syphilis
Vaccination Panel
Anti-HBs
Rubella IgG
Anti-HAV
>6 more medical value
solutions
Gastrointestinal
cDiff
>3 more medical value
solutions
Antimicrobial
Stewardship
MTB-RIF/INH
>6 more medical value
solutions
HIV-1
CT/NG
CMV
Flu A/B/RSV
HBV
TV/MG
HSV-1/2/VZV
MTB
Zika IgG
Zika IgM
HCV
HPV
EBV
ΜΑΙ
HIV-1/2 Qual
HCV DUO
BKV
MPLX Respiratory
Dengue IgG
Dengue IgM
Anti-HEV IgG
CMV IgG
>5 more high medical
Dengue Ag
Anti-HEV IgM
CMV IgM
value solutions
Chik IgG
CMV Avidity
Chik IgM
Toxo IgG
Lyme IgG
Anti-HAV
Anti-HAV IgM
HBsAg
HBsAg confirmatory
HBsAg quant
Anti-HBs
Anti-HBc
Anti-HBc IgM
Anti-HBe
HBeAg
Anti-HCV
HIV combi PT
HIV DUO
HIV confirmatory
HTLV I/II
Syphilis
Genital Ulcer Panel
Vaginal Discharge Panel
Mycoplasma Panel
HBeAg quant
Anti-HBc quant
>10 more medical value
solutions
Toxo IgM
Toxo Avidity
EBV EBNA IgG
EBV VCA IgG
EBV IgM
Adeno Quant
HSV-1/2/VZV
>3 more medical
value solutions
Chagas
HTLV I/II
Lyme IgM
CMV IgG
>2 more medical
MPX
value solutions
WNV
DPX
HEV
CHIKV/DENV
Zika (US-IVD)
Babesia
Zika (CE-IVD)
>2 more medical value
solutions
RPR
HSV-1 IgG
HSV-2 IgG
IA: Investigational Assay, US-IVD: Exclusive to US
Sepsis
PCT
IL-6
IL-6 US neonatal & adult
New Early Sepsis Marker
Digital Decision Support
On market
In development
Considered
50View entire presentation